American Cyanamid Co. v. American Home Assurance Co.

30 Cal. App. 4th 969, 35 Cal. Rptr. 2d 920, 94 Cal. Daily Op. Serv. 9416, 94 Daily Journal DAR 17373, 1994 Cal. App. LEXIS 1250
CourtCalifornia Court of Appeal
DecidedDecember 9, 1994
DocketA062499
StatusPublished
Cited by15 cases

This text of 30 Cal. App. 4th 969 (American Cyanamid Co. v. American Home Assurance Co.) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Cyanamid Co. v. American Home Assurance Co., 30 Cal. App. 4th 969, 35 Cal. Rptr. 2d 920, 94 Cal. Daily Op. Serv. 9416, 94 Daily Journal DAR 17373, 1994 Cal. App. LEXIS 1250 (Cal. Ct. App. 1994).

Opinion

Opinion

DOSSEE, J.

This is an action for declaratory relief brought by an insured, American Cyanamid Company, to determine the duty of its various insurers to defend and indemnify American Cyanamid in an underlying lawsuit for anticompetitive conduct. The action was brought against three primary insurers and numerous excess insurers, all of whose policies were in effect from 1966 to 1986.

The three primary insurers—Insurance Company of North America (INA), American Home Assurance Company (AHA) and Commercial Union (CU) —moved for summary adjudication of the duty to defend. The trial court granted the motion, finding no duty to defend. 1 Plaintiff, American Cyanamid, appeals.

Facts

The Underlying Lawsuit

American Cyanamid is a research-based biotechnology and chemical company which since 1967 has developed, manufactured and sold “chemical light products,” e.g., chemical lightsticks, safety lights, light wands and other products used especially by the United States military.

*973 Chemical Device Corp. (CDC) is also in the business of manufacturing and selling chemical light products, but it has been in existence only since January 1986.

In 1989 CDC filed suit in federal court against American Cyanamid seeking damages for CDC’s loss of business resulting from American Cyanamid’s monopolistic and anticompetitive conduct. CDC’s complaint alleged two broad courses of conduct by American Cyanamid—one from 1967 to 1986 and the second from 1986 to the present. The pivotal date, 1986, was the date CDC itself entered the market for chemical light products.

Because the insurance coverage action before us pertains only to insurance policies in effect before 1986, the allegations in the underlying lawsuit of most interest are those concerning American Cyanamid’s pre-1986 conduct. In essence, the complaint alleges that American Cyanamid abused its patents in an effort to restrict competition and monopolize the market. Specifically, the complaint alleges that American Cyanamid developed certain chemical light products with funding from the United States Government pursuant to research and development contracts. These contracts required American Cyanamid to grant to the government a royalty-free license for its inventions and, further, to disclose in its patent applications, and in any resulting patents, that the patent was the result of a government-funded research and development contract. The purpose of this disclosure was to make competing suppliers aware of the government’s royalty-free license and to enable the government to purchase chemical light products from those suppliers without being exposed to patent infringement claims.

The complaint further alleges that from 1972 to 1986 American Cyanamid failed to make the requisite disclosure on its patent applications and thus failed to provide the government with a royalty-free license for its inventions. As a result, the government and potential competitors were led to believe that potential competitors would infringe American Cyanamid’s patents if they manufactured and sold chemical light products to the government. American Cyanamid thereby created a monopoly in the government market for chemical light products.

As to the post-1986 conduct, the complaint alleges that in February 1986 CDC submitted a bid to the United States Government’s buying agent for the military services and thereby presented the first competition for the sale of chemical light products to the government. American Cyanamid thereupon engaged in a variety of activities designed to destroy the competition and perpetuate its monopoly over the market.

*974 Although CDC’s complaint raises several legal theories, rulings by the federal district court upon motions by the parties narrowed the claims of CDC to (1) a claim for monopolization in violation of section 2 of the Sherman Act and (2) state claims for theft of trade secrets, unfair competition and intentional interference with contractual relations.

The Insurance Policies

American Cyanamid was insured under eight separate primary policies during the period from 1966 to 1986. Although the liability policies are all worded differently, all provide coverage for damages the insured must pay for “advertising injury,” which is defined to include damage resulting from, among other things, unfair competition. The dispute here concerns timing: whether the pre-1986 policies provide coverage even though the injury to CDC did not occur (and indeed could not have occurred as CDC did not even exist) until after the policies had expired.

The Insurance Coverage Action

In its action for declaratory relief American Cyanamid alleged that the pre-1986 insurance policies provided coverage for the CDC lawsuit because that lawsuit was based on “acts or offenses occurring throughout the [policy] periods.” It was American Cyanamid’s position that coverage was triggered by the alleged anticompetitive conduct during the policy periods.

In their motion for summary adjudication, the primary insurers did not directly raise the issue of when the insurance coverage was triggered. Instead, the insurers asserted that the “offense” of unfair competition could not have been committed before 1986 as CDC did not exist as a competitor.

For purposes of the motion, American Cyanamid and the primary insurers stipulated to certain facts, including the following: “CDC was incorporated on or about January 28, 1986. CDC makes no claim in the Underlying Litigation that it was either in business or otherwise in competition with plaintiff Cyanamid prior to January of 1986.” The parties also stipulated that the sole issue to be adjudicated was the following: “Does the fact that CDC did not exist as a competitor of American Cyanamid prior to January 28, 1986 preclude a duty to defend American Cyanamid in the underlying litigation under the advertising injury liability provisions of each of the primary policies at issue?”

The trial court concluded as follows: “The Court finds that the fact that CDC did not exist as a competitor of American Cyanamid prior to January *975 28, 1986 precludes a duty on the part of the Primary Insurers to defend American Cyanamid in the underlying litigation under the advertising liability provision of the primary policies at issue. Absent the existence of a competitor there is no duty to defend an allegation of unfair competition.”

Discussion

There is no question that an insurer is not required to defend an action where undisputed facts conclusively show that the underlying conduct is not within the coverage of the policy. (Montrose Chemical Corp. v. Superior Court (1993) 6 Cal.4th 287, 298 [24 Cal.Rptr.2d 467, 861 P.2d 1153].) In Montrose, the court reiterated that on a motion for summary judgment seeking a declaration of the nonexistence of a duty to defend, the insurer must establish the absence of any potential for coverage. (6 Cal.4th at p.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Great Am. E&S Ins. Co. v. Theos Med. Sys., Inc.
357 F. Supp. 3d 953 (N.D. California, 2019)
Big 5 Sporting Goods Corp. v. Zurich American Insurance
957 F. Supp. 2d 1135 (D. California, 2013)
Mylan Laboratories Inc. v. American Motorists Insurance
700 S.E.2d 518 (West Virginia Supreme Court, 2010)
Standard Fire Ins. v. Spectrum Community Ass'n
46 Cal. Rptr. 3d 804 (California Court of Appeal, 2006)
Standard Fire Insurance v. Spectrum Community Ass'n
141 Cal. App. 4th 1117 (California Court of Appeal, 2006)
Atlantic Mutual Insurance v. J. Lamb, Inc.
123 Cal. Rptr. 2d 256 (California Court of Appeal, 2002)
Upland Anesthesia Medical Group v. Doctors' Co.
123 Cal. Rptr. 2d 94 (California Court of Appeal, 2002)
Cunningham v. Universal Underwriters
120 Cal. Rptr. 2d 162 (California Court of Appeal, 2002)
Smith v. TCI Communications, Inc.
981 P.2d 690 (Colorado Court of Appeals, 1999)
Armstrong World Industries, Inc. v. Aetna Casualty & Surety Co.
45 Cal. App. 4th 1 (California Court of Appeal, 1996)
A-Mark Financial Corp. v. Cigna Property & Casualty Co.
34 Cal. App. 4th 1179 (California Court of Appeal, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
30 Cal. App. 4th 969, 35 Cal. Rptr. 2d 920, 94 Cal. Daily Op. Serv. 9416, 94 Daily Journal DAR 17373, 1994 Cal. App. LEXIS 1250, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-cyanamid-co-v-american-home-assurance-co-calctapp-1994.